Samsung Bioepis Biosimilars Report Slams ‘Stagnant’ US Adalimumab Uptake
Figures From Q4 Reveal Humira Rivals Have Captured Just 2% Of The Market
• By David Wallace
Humira biosimilars have so far captured just 2% of the US market • Source: Shutterstock 
